scholarly journals MP385ELECTIVE PARATHYROID SURGERY IN DIALYSIS PATIENTS WITH CHRONIC RENAL FAILURE AND MORTALITY

2016 ◽  
Vol 31 (suppl_1) ◽  
pp. i468-i468
Author(s):  
Deborah Sylvester ◽  
Rishi Srivastava ◽  
Archie Lamplugh ◽  
Victoria Allgar ◽  
Christopher Snowden ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Parathyroid Surgery ◽  
Dialysis Patients

METABOLIC SYNDROME IN DIALYSIS PATIENTS

2016 ◽  
pp. 7-11
Author(s):  
Vinh Phu Hoang ◽  
Tam Vo ◽  
Van Tien Le ◽  
Thi Hoai Huong Vo
Keyword(s):  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Renal Failure ◽  
Chronic Renal Failure ◽  
Artificial Kidney ◽  
Dialysis Patients ◽  
Cross Sectional ◽  
Average Value ◽  
The Metabolic Syndrome ◽  
End Stage

Objective: To review disorders elements of the metabolic syndrome in patients with end-stage chronic renal failure on dialysis cycle. Materials and methods: A cross sectional descriptive study of 85 patients including end-stage chronic renal failure in dialysis cycle from 5/2015 - 9/2016 at the Department of Artificial Kidney, Hue Central Hospital. Results: The prevalence of metabolic syndrome in dialysis patients was 37.65%. The prevalence of abdominal obesity was 30.6%; The prevalence of hypertension was 72.9%, the average value systolic blood pressure and diastolic blood pressure were 142.24 ± 27.53, 80.35 ± 12.48 mmHg; The prevalence of hyperglycemia was 28%, the average value blood glucose was 4.9 ± 1.19 mmol/l; The prevalence of triglyceride increase was 34.1%, the average value triglyceride was 1.59 ± 0.84 mmol/l. The prevalence of HDL-C increase was 47.1%, the average value HDL-C was 1.24 ± 0.33 mmol/l. Conclusion: The prevalence of metabolic syndrome in dialysis patients is very high, in which hypertension and HDL disturbances are the highest. Key words: chronic renal failure, dialysis, metabolic syndrome

Serum Ferritin in Non-Dialysis Patients with Chronic Renal Failure: Relation to Bone Marrow Iron Stores

2009 ◽  
Vol 30 (4) ◽  
pp. 337-344 ◽  
Author(s):  
Nils Milman ◽  
Susanne Bangsbøll ◽  
Nils Strandberg Pedersen ◽  
Jakob Visfeldt
Keyword(s):  
Bone Marrow ◽  
Renal Failure ◽  
Chronic Renal Failure ◽  
Serum Ferritin ◽  
Dialysis Patients ◽  
Iron Stores ◽  
Bone Marrow Iron

Serum Levels of Soluble Adhesion Molecules in Chronic Renal Failure and Dialysis Patients

Nephron ◽  
1998 ◽  
Vol 79 (4) ◽  
pp. 399-407 ◽  
Author(s):  
Mario Bonomini ◽  
Marcella Reale ◽  
Patrizia Santarelli ◽  
Stefano Stuard ◽  
Nicola Settefrati ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Adhesion Molecules ◽  
Serum Levels ◽  
Dialysis Patients ◽  
Soluble Adhesion Molecules

Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients

2005 ◽  
Vol 43 (5) ◽  
Author(s):  
Xiaohong Zhang ◽  
Matthias Frischmann ◽  
Rose Kientsch-Engel ◽  
Katharina Steinmann ◽  
Helga Stopper ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Advanced Glycation End Products ◽  
Uremic Toxins ◽  
Dialysis Patients ◽  
Advanced Glycation ◽  
Glycation End Products ◽  
End Products ◽  
Immunosorbent Assays

AbstractAdvanced glycation end-products are uremic toxins that accumulate in the serum and tissues of patients with chronic renal failure. Here, we established two enzyme-linked immunosorbent assays (ELISAs) for N

Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients

2005 ◽  
Author(s):  
June D Cody ◽  
Conal Daly ◽  
Marion K Campbell ◽  
Izhar Khan ◽  
Kannaiyan S Rabindranath ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Recombinant Human Erythropoietin ◽  
Dialysis Patients ◽  
Human Erythropoietin

Increased Endothelin-1 Mrna Expression in Peripheral Blood Monocytes of Dialysis Patients

1997 ◽  
Vol 17 (6) ◽  
pp. 595-601 ◽  
Author(s):  
Isao Ebihara ◽  
Tsukasa Nakamura ◽  
Toshimasa Takahashi ◽  
Yasuhiko Tomino ◽  
Noriaki Shimada ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Peripheral Blood ◽  
Mrna Level ◽  
Mrna Levels ◽  
Healthy Controls ◽  
Blood Monocytes ◽  
Dialysis Patients ◽  
Peripheral Blood Monocytes ◽  
Different Types

Objective To compare plasma endothelin (ET)-1 level and ET-1 mRNA level in peripheral blood monocytes of patients undergoing hemodialysis (HD) or continuous ambulatory peritoneal dialysis (CAPD). Design Endothelin-1 mRNA level in peripheral blood monocytes and plasma ET -1 level were studied in 30 HD patients, 15 CAPD patients, 20 chronic renal failure patients not being dialyzed, and 20 normal healthy controls. Hemodialysis patients were dialyzed three times per week with a bicarbonate dialysate. Different types of dialyzer membrane, viz., cellulose triacetate, cuprophane, poly-sulfone, polyacrylonitrile, and ethylenevinylalcohol were used in 8,6,6,5, and 5 patients, respectively. Continuous ambulatory peritoneal dialysis patients were dialyzed with four daily exchanges of a 2-L dialysate containing glucose at a concentration of 1.5% to 2.5%. Results Higher levels of ET -1 mRNA in monocytes were observed in HD patients than in CAPD patients (p < 0.01), chronic renal failure patients (p < 0.01), or normal healthy controls (p < 0.001). The level of ET -1 mRNA in monocytes at the end of HD was not significantly higher than that at the start of HD. ln addition, these mRNA levels in HD patients showed littledifference with different types of dialysis membrane. Plasma ET -1 level in HD patients (10.2 ± 2.4 pg/mL) was also higher than that in CAPD patients (7.8 ± 1.6 pg/mL, p < 0.01), in chronic renal failure patients (4.8 ± 1.2 pg/mL, p < 0.01), or in normal controls (2.6 ± 0.8 pg/mL, p < 0.001). Conclusion Dialysis itself did not significantly affect ET -1 mRNA levels in monocytes. Chronic stimulation of peripheral blood monocytes may be associated with higher levels of ET -1 mRNA and plasma ET -1 in HD patients than in CAPD patients.

Sign in / Sign up

Export Citation Format

Share Document